Focus:
Healthcare services provider Centene has committed up to $100m to fund research at the Washington University School of Medicine in St Louis for developing personalised medicines to treat certain debilitating...
Celgene has submitted a biologics licence application to the US Food and Drug Administration seeking approval for luspatercept to treat patients suffering from anaemia.
Sanofi has concluded the research and option phase of an RNAi therapeutics partnership in rare genetic diseases forged with biopharmaceutical company Alnylam Pharmaceuticals in 2014.
Drugmakers Jazz Pharmaceuticals, Lundbeck and Alexion Pharmaceuticals have agreed to pay a total of $122.6m to settle allegations of paying kickbacks via copay assistance foundations.
Pfizer has announced that the US Food and Drug Administration (FDA) has accepted its request to expand the indications for Ibrance (palbociclib) to include the treatment of men with breast...
Gilead has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for antiviral Descovy (emtricitabine and tenofovir alafenamide) for pre-exposure prophylaxis (PrEP) to reduce...
Bristol-Myers Squibb (BMS) has announced that the National Institute of Health and Care Excellence (NICE) has recommends Opdivo (nivolumab) and Yervoy (ipilimumab) combination therapy to treat National Health Service (NHS)...
Belgium-based AgomAb Therapeutics has raised funds in a series A round to support the development of molecular therapies for the regeneration of damaged tissues.
Novartis has filed a lawsuit against Amgen for allegedly trying to inappropriately back out of their collaboration agreements covering the development and commercialisation of migraine drug Aimovig.
Global healthcare company Roivant Sciences and Chinese drugmaker Sinovant Sciences have launched a new biopharmaceutical firm Cytovant Sciences to cater to patients across Asia.
Go Top
